National Institute on Drug Abuse
Division of Treatment Research and Development
RAB - Branch Functions
Regulatory Affairs Branch
- To provide technical and administrative leadership to DTR&D's effort
in recruiting industry and other development partners, acquiring new testing
compounds; to identify barriers and propose development strategies.
- To maintain contact with the U.S. Food and Drug Administration (FDA) to
lead the filing of Investigational New Drug (IND) applications, and New Drug
Applications (NDA) as new medications enter or complete clinical studies.
- To provide consultation and advice on nonclinical and clinical medication
development requirements and strategy to NIDA grantees, contractors, and other
interested parties regarding projects of mutual interest.
- To provide guidance and support to potential development partners, including
developing and negotiating Cooperative Research and Development Agreements,
Material Transfer Agreements, and interagency agreements with other federal
agencies.
- To lead DTR&D patent and technology transfer activities through contacts
with Offices of the General Counsel, Office of the Secretary (HHS), and the
NIH Office of Technology Transfer.
|
|